You're almost done! We just need to verify your account before you canstart using it.
Note: Rediff will never share your number with any company for marketing purpose.
Rediff reports Q4 numbers with PAT at Rs 18.6 crore vs Rs 31 crore, (YoY). (ET Now) #Earnings #money
mukesh dishman slowly going to achieve intraday target of 73 #money
mukesh buy it for intraday target of 73 #money
Marina Boseyes :-*
mukesh buy Dishman pharma at current level as Q4 earnings of company very strong for futurekeep sl of 69 tgt. 88 #money
Vinod Kashyap BUY #money
Rediff reports Q4 numbers with sales at Rs 345 crore vs Rs 350 crore, (YoY). (ET Now) #Earnings #money
sunil kumar sell sell short term taregt 62 #money
ATAULLAH KHAN insaallah buy dishman strong fundamental with a target of 88 #money
Rediff : We are in the process of altering forex strategy to curb losses. (ET Now) #money
Rediff reports Q3 numbers with sales at Rs 318 crore vs 265 crore, (YoY). (ET Now) #Earnings #money